The gene editing tool known as CRISPR-Cas9 is changing what’s possible for treating a wide range of diseases caused by ...

Genetic manipulation – or gene editing – is a concept that describes altering the genetic material (DNA) of an organism.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

Study shows gene editing restores drug sensitivity by targeting NRF2, with potential across multiple tumor types.

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...

A quiet hope has started to grow among people living with stubborn cholesterol problems as researchers report early success ...

Earlier this month, CRISPR Therapeutics announced positive Phase 1 data for its investigational in vivo CRISPR/Cas9 therapy CTX310, which showed substantial and durable reductions in key lipid levels ...

According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold ...

CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its ...

Genetic medicines-focused Scribe Therapeutics is racing toward the clinic on the heels of a preclinical data drop for three ...